AVECHO BIOTECHNOLOGY LIMITED — Director's Dealing 2013

Jul 23, 2013

==> picture [128 x 99] intentionally omitted <==

24 July 2013

COMPANY ANNOUNCEMENT

Phosphagenics Limited

Change in Directors Interest

Attached for release to the market is an Appendix 3Z (Final Director’s Interest Notice) following the resignation of Dr E Ogru as a Director of the Company.

END RELEASE

About Phosphagenics

Phosphagenics Limited is commercialising drug delivery applications based on its novel transdermal (drugs administered via skin) TPM® – Targeted Penetration Matrix technology. TPM® is a patient friendly and cost effective system used to deliver proven pharmaceutical and nutraceutical products.

The lead product advancing through clinical trials is an oxycodone and oxymorphone matrix system for the relief of chronic pain.

Phosphagenics’ shares are listed on the Australian Securities Exchange (POH) and its ADR – Level 1 program in the US is with The Bank of New York Mellon (PPGNY).

www.phosphagenics.com

www.elixia.com.au

Phosphagenics Limited

ACN 056 482 403 ABN 32 056 482 403

11 Duerdin Street, Clayton Vic 3168 Telephone: 61 3 9565 1119 Facsimile: 61 3 9565 1151 Web page: www.phosphagenics.com Email: info@phosphagenics.com

Appendix 3Z Final Director’s Interest Notice

Rule 3.19A.3

Appendix 3Z

Final Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity PHOSPHAGENICS LIMITED ABN 32 056 482 403

We (the entity) give ASX the following information under listing rule 3.19A.3 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of director	OGRU, Esra
Date of last notice	7 May 2013 (3Y)
Date that director ceased to be director	18 July 2013

Part 1 – Director’s relevant interests in securities of which the director is the registered holder In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Number & class of securities

5,711,610 Ordinary Shares

2,000,000 Conditional Rights

• See chapter 19 for defined terms.

Appendix 3Z Page 1

11/3/2002

Appendix 3Z Final Director’s Interest Notice

Part 2 – Director’s relevant interests in securities of which the director is not the registered holder

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Name of holder & nature of interestNote: Provide details of the circumstances giving riseto the relevant interestMr V Isikgel[Mr Isikgel is Dr Ogru’s husband]	Number & class of securities215,000 Ordinary Shares

Part 3 – Director’s interests in contracts

Detail of contract	Not applicable
Nature of interest
Name of registered holder(if issued securities)
No. and class of securities to whichinterest relates

p\asx\eo 24 07 13

• See chapter 19 for defined terms.

Appendix 3Z Page 2

11/3/2002